Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 67 of 120)
- Relevance
  Sort by

Prostate Cancer Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
105 Pages
Global

From

€3500EUR$4,255USD£3,182GBP

Geriatric Medicines Market 2025-2029

 Report
February 2025
231 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma), and Region - Forecast to 2027

 Report
May 2022
270 Pages
Global

From

€4362EUR$4,950USD£3,831GBP

Bio-Pharma Market 2025-2029

 Report
June 2025
229 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
December 2023
230 Pages
Global

From

€2159EUR$2,450USD£1,896GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032

 Report
February 2024
120 Pages
New Zealand, Australia New Zealand, Australia

From

€2458EUR$2,789USD£2,159GBP

Idiopathic Pulmonary Fibrosis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
110 Pages
Global

From

€4186EUR$4,750USD£3,677GBP

Mantle Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€3965EUR$4,500USD£3,483GBP

Transplant Immunosuppressive Drug Market - Forecasts from 2023 to 2028

 Report
June 2023
113 Pages
Global

From

€3921EUR$4,450USD£3,444GBP

Modular Manufacturing Facilities Market in Pharmaceutical and Biotechnology: Industry Trends and Global Forecasts, 2023-2035

 Report
February 2023
336 Pages
Global

From

€4229EUR$4,799USD£3,714GBP

Central Nervous System Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€881EUR$1,000USD£774GBP

€1102EUR$1,250USD£968GBP

Breast Cancer Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
120 Pages
Global

From

€4186EUR$4,750USD£3,677GBP

Cancer Biologics Market 2025-2029

 Report
March 2025
243 Pages
Global

From

€2203EUR$2,500USD£1,935GBP

Idiopathic Pulmonary Fibrosis Treatment Market

 Report
September 2025
150 Pages
Global

From

€3921EUR$4,450USD£3,444GBP

Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029

 Report
July 2024
335 Pages
Global

From

€4362EUR$4,950USD£3,831GBP

PD-1 and PD-L1 Inhibitors Market - Global Strategic Business Report

 Report
December 2025
376 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Immunotoxins - Global Strategic Business Report

 Report
December 2025
377 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Autoimmune Drugs - Global Strategic Business Report

 Report
December 2025
287 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Anti-Inflammatory Drugs - Global Strategic Business Report

 Report
December 2025
488 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

Autoimmune Disease Therapeutics - Global Strategic Business Report

 Report
December 2025
263 Pages
Global

From

€5155EUR$5,850USD£4,528GBP

2,397 Results (Page 67 of 120)
- 1
- 65
- 66
- 67
- 68
- 69

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.